Literature DB >> 31734115

Genetic variation in CFTR and modifier loci may modulate cystic fibrosis disease severity.

Alekh Paranjapye1, Manon Ruffin2, Ann Harris3, Harriet Corvol4.   

Abstract

In patients with cystic fibrosis (CF), genetic variants within and outside the CFTR locus contribute to the variability of the disease severity. CFTR transcription is tightly regulated by cis-regulatory elements (CREs) that control the three-dimensional structure of the locus, chromatin accessibility and transcription factor recruitment. Variants within these CREs may contribute to the pathophysiology and to the phenotypic heterogeneity by altering CFTR transcript abundance. In addition to the CREs, variants outside the CFTR locus, namely "modifiers genes", may also be associated with the clinical variability. This review addresses variants at the CFTR locus itself and CFTR CREs, together with the outcomes of the latest modifier gene studies with respect to the different CF phenotypes.
Copyright © 2019 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CFTR; Cystic fibrosis; Genetics; Genomics; Modifier genes; cis-regulatory elements

Year:  2019        PMID: 31734115      PMCID: PMC7036019          DOI: 10.1016/j.jcf.2019.11.001

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  61 in total

1.  Identification and functional analysis of a novel human KRAB/C2H2 zinc finger gene ZNF300.

Authors:  Deming Gou; Jun Wang; Li Gao; Yan Sun; Xiao Peng; Jian Huang; Wenxin Li
Journal:  Biochim Biophys Acta       Date:  2004-01-20

2.  Oxidative stress regulates CFTR gene expression in human airway epithelial cells through a distal antioxidant response element.

Authors:  Zhaolin Zhang; Shih-Hsing Leir; Ann Harris
Journal:  Am J Respir Cell Mol Biol       Date:  2015-03       Impact factor: 6.914

3.  Heritability of lung disease severity in cystic fibrosis.

Authors:  Lori L Vanscoy; Scott M Blackman; Joseph M Collaco; Amanda Bowers; Teresa Lai; Kathleen Naughton; Marilyn Algire; Rita McWilliams; Suzanne Beck; Julie Hoover-Fong; Ada Hamosh; Dave Cutler; Garry R Cutting
Journal:  Am J Respir Crit Care Med       Date:  2007-03-01       Impact factor: 21.405

4.  Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization.

Authors:  T V Strong; K Boehm; F S Collins
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

5.  A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis.

Authors:  S M Blackman; S Hsu; S E Ritter; K M Naughton; F A Wright; M L Drumm; M R Knowles; G R Cutting
Journal:  Diabetologia       Date:  2009-07-08       Impact factor: 10.122

6.  Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2.

Authors:  Fred A Wright; Lisa J Strug; Vishal K Doshi; Clayton W Commander; Scott M Blackman; Lei Sun; Yves Berthiaume; David Cutler; Andreea Cojocaru; J Michael Collaco; Mary Corey; Ruslan Dorfman; Katrina Goddard; Deanna Green; Jack W Kent; Ethan M Lange; Seunggeun Lee; Weili Li; Jingchun Luo; Gregory M Mayhew; Kathleen M Naughton; Rhonda G Pace; Peter Paré; Johanna M Rommens; Andrew Sandford; Jaclyn R Stonebraker; Wei Sun; Chelsea Taylor; Lori L Vanscoy; Fei Zou; John Blangero; Julian Zielenski; Wanda K O'Neal; Mitchell L Drumm; Peter R Durie; Michael R Knowles; Garry R Cutting
Journal:  Nat Genet       Date:  2011-05-22       Impact factor: 38.330

Review 7.  Cell-Selective Regulation of CFTR Gene Expression: Relevance to Gene Editing Therapeutics.

Authors:  Hannah Swahn; Ann Harris
Journal:  Genes (Basel)       Date:  2019-03-19       Impact factor: 4.096

8.  Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci.

Authors:  Jiafen Gong; Fan Wang; Bowei Xiao; Naim Panjwani; Fan Lin; Katherine Keenan; Julie Avolio; Mohsen Esmaeili; Lin Zhang; Gengming He; David Soave; Scott Mastromatteo; Zeynep Baskurt; Sangook Kim; Wanda K O'Neal; Deepika Polineni; Scott M Blackman; Harriet Corvol; Garry R Cutting; Mitchell Drumm; Michael R Knowles; Johanna M Rommens; Lei Sun; Lisa J Strug
Journal:  PLoS Genet       Date:  2019-02-26       Impact factor: 5.917

9.  Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality.

Authors:  Antoinette Moran; Jordan Dunitz; Brandon Nathan; Asad Saeed; Bonnie Holme; William Thomas
Journal:  Diabetes Care       Date:  2009-06-19       Impact factor: 19.112

10.  A complex intronic enhancer regulates expression of the CFTR gene by direct interaction with the promoter.

Authors:  Christopher J Ott; Magdalena Suszko; Neil P Blackledge; Jane E Wright; Gregory E Crawford; Ann Harris
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

View more
  3 in total

1.  Two Cases of Cystic Fibrosis with Compound Heterozygous Variants Reported for the First Time

Authors:  Sinem Yalçıntepe; Hakan Gürkan; Engin Atlı; Niyazi Cenk Sayın; Ümit Nusret Başaran
Journal:  Balkan Med J       Date:  2020-02-28       Impact factor: 2.021

2.  The era of CFTR modulators: improvements made and remaining challenges.

Authors:  Sara Cuevas-Ocaña; Onofrio Laselva; Julie Avolio; Raffaella Nenna
Journal:  Breathe (Sheff)       Date:  2020-06

3.  Impact of newborn screening for cystic fibrosis on clinical outcomes of pediatric patients: 10 years' experience in Lodz Voivodship.

Authors:  M Olszowiec-Chlebna; E Mospinek; J Jerzynska
Journal:  Ital J Pediatr       Date:  2021-04-09       Impact factor: 2.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.